Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Clemens Schirmer

Neurological Surgery Danville, PA Medical Doctor

NPI 1649486069 CMS profile 165273

100 N Academy Ave, Danville, PA 17822

Open in the dashboard

General payments

$217,551

232 records reported · program years 2019–2025

Research payments

$49,800

Paid to them · 53 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$845,395 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Clemens Schirmer of Danville, PA is reported in the CMS Open Payments database as having received $217,551 across 232 general payments and $49,800 in research payments paid to them. Separately, studies naming them as principal investigator received $845,395 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,355 86
2025 Research $9,600 8
2024 General $17,814 43
2024 Research $12,500 13
2023 General $92,380 67
2023 Research $10,000 12
2022 General $29,402 22
2022 Research $10,300 12
2021 General $74 1
2021 Research $7,400 8
2019 General $1,526 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Clemens Schirmer
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Clemens Schirmer were reported at $76,355. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Clemens Schirmer Neurological Surgery median Middle half National median
2019 $1,526 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $74 $387 $105–$2,432 $132
2022 $29,402 $542 $139–$2,989 $149
2023 $92,380 $534 $145–$2,697 $160
2024 $17,814 $574 $155–$3,046 $164
2025 $76,355 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Balt USA, LLC $115,007 39 payments
  2. Stryker Corporation $33,928 45 payments
  3. Medtronic, Inc. $28,286 57 payments
  4. Siemens Medical Solutions USA, Inc. $11,862 17 payments
  5. MicroVention, Inc. $10,414 27 payments
  6. Accriva Diagnostics Inc. $6,800 3 payments
  7. Penumbra, Inc. $3,087 22 payments
  8. Vesalio, Inc. $3,000 1 payment
  9. Canon Medical Systems USA, Inc. $2,000 2 payments
  10. NICO Corporation $1,500 3 payments
  11. Other $1,665 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $177,680 40 payments
  2. Travel and Lodging $24,236 83 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,350 4 payments
  4. Food and Beverage $5,784 102 payments
  5. Honoraria $2,500 3 payments
Products named General payments · program years 2019–2025
  1. STEALTHSTATION S8 PLATFORM $9,646 15 payments
  2. SYNCHRO SELECT $8,381 9 payments
  3. Optima Coil System $7,922 12 payments
  4. Ballast 088 Long Sheath $7,542 3 payments
  5. ECLIPSE 2L $6,266 4 payments
  6. BROADWAY 8 $5,950 4 payments
  7. CorPath Imaging System $5,375 13 payments
  8. STENT $5,085 5 payments
  9. Magic Infusion Catheter $4,800 1 payment
  10. Barricade Coil System $4,800 1 payment
  11. Other $39,615 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $46,800 52 payments
  2. Vesalio, Inc. $3,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

31

Median for Neurosurgery: 83

Drug cost

$380

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 31 $380

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$91,792

Medicare's payments for the services billed

Medicare patients

152

Average age 73

Services billed

648

80 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Diabetes 35%
Ischemic heart disease 34%
Depression 34%
Chronic kidney disease 32%
Atrial fibrillation 28%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

285 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record